38 results on '"Parmeggiani, L"'
Search Results
2. INFANTILE ONSET FOCAL EPILEPSY AND EPILEPTIC ENCEPHALOPATHIES ASSOCIATED WITH PCDH19 GENE MUTATIONS: NEW DE NOVO AND FAMILIAL MUTATIONS: 001
- Author
-
Marini, C, Mei, D, Parmeggiani, L, Norci, V, Calado, E, Moreira, A, Ferrari, A, Pisano, T, Battaglia, D, and Guerrini, R
- Published
- 2010
3. Abnormal corticomuscular and intermuscular coupling in high-frequency rhythmic myoclonus
- Author
-
Grosse, P., Guerrini, R., Parmeggiani, L., Bonanni, P., Pogosyan, A., and Brown, P.
- Published
- 2003
4. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: A multicenter study
- Author
-
Trivisano, M., Pietrafusa, N., Terracciano, A., Marini, C., Mei, D., Darra, F., Accorsi, P., Battaglia, Domenica Immacolata, Caffi, L., Canevini, M. P., Cappelletti, S., Cesaroni, E., de Palma, L., Costa, Paolo, Cusmai, R., Giordano, Liliana, Ferrari, A., Freri, E., Fusco, L., Granata, T., Martino, T., Mastrangelo, Marica, Bova, S. M., Parmeggiani, L., Ragona, F., Sicca, F., Striano, P., Specchio, L. M., Tondo, I., Zambrelli, E., Zamponi, N., Zanus, C., Boniver, C., Vecchi, M., Avolio, C., Dalla Bernardina, B., Bertini, Enrico Silvio, Guerrini, R., Vigevano, F., Specchio, N., Battaglia D. (ORCID:0000-0003-0491-4021), Costa P., Giordano L., Mastrangelo M., Bertini E., Trivisano, M., Pietrafusa, N., Terracciano, A., Marini, C., Mei, D., Darra, F., Accorsi, P., Battaglia, Domenica Immacolata, Caffi, L., Canevini, M. P., Cappelletti, S., Cesaroni, E., de Palma, L., Costa, Paolo, Cusmai, R., Giordano, Liliana, Ferrari, A., Freri, E., Fusco, L., Granata, T., Martino, T., Mastrangelo, Marica, Bova, S. M., Parmeggiani, L., Ragona, F., Sicca, F., Striano, P., Specchio, L. M., Tondo, I., Zambrelli, E., Zamponi, N., Zanus, C., Boniver, C., Vecchi, M., Avolio, C., Dalla Bernardina, B., Bertini, Enrico Silvio, Guerrini, R., Vigevano, F., Specchio, N., Battaglia D. (ORCID:0000-0003-0491-4021), Costa P., Giordano L., Mastrangelo M., and Bertini E.
- Abstract
Objective: PCDH19-related epilepsy is an epileptic syndrome with infantile onset, characterized by clustered and fever-induced seizures, often associated with intellectual disability (ID) and autistic features. The aim of this study was to analyze a large cohort of patients with PCDH19-related epilepsy and better define the epileptic phenotype, genotype-phenotype correlations, and related outcome-predicting factors. Methods: We retrospectively collected genetic, clinical, and electroencephalogram (EEG) data of 61 patients with PCDH19-related epilepsy followed at 15 epilepsy centers. All consecutively performed EEGs were analyzed, totaling 551. We considered as outcome measures the development of ID, autistic spectrum disorder (ASD), and seizure persistence. The analyzed variables were the following: gender, age at onset, age at study, genetic variant, fever sensitivity, seizure type, cluster occurrence, status epilepticus, EEG abnormalities, and cognitive and behavioral disorders. Receiver operating characteristic curve analysis was performed to evaluate the age at which seizures might decrease in frequency. Results: At last follow-up (median = 12 years, range = 1.9-42.1 years), 48 patients (78.7%) had annual seizures/clusters, 13 patients (21.3%) had monthly to weekly seizures, and 12 patients (19.7%) were seizure-free for ≥2 years. Receiver operating characteristic analysis showed a significant decrease of seizure frequency after the age of 10.5 years (sensitivity = 81.0%, specificity = 70.0%). Thirty-six patients (59.0%) had ID and behavioral disturbances. ASD was present in 31 patients. An earlier age at epilepsy onset emerged as the only predictive factor for ID (P = 0.047) and ASD (P = 0.014). Conversely, age at onset was not a predictive factor for seizure outcome (P = 0.124). Significance: We found that earlier age at epilepsy onset is related to a significant risk for ID and ASD. Furthermore, long-term follow-up showed that after the age of 10 years, seizur
- Published
- 2018
5. Epilepsy and paroxysmal dyskinesia: Co-occurrence and differential diagnosis
- Author
-
Guerrini, R., Parmeggiani, L., Giorgio CASARI, Guerrini, R, Parmeggiani, L, and Casari, GIORGIO NEVIO
- Published
- 2002
6. Locus for paroxysmal kinesigenic dyskinesia maps to human chromosome 16
- Author
-
Guerrini R, Parmeggiani L, Bonanni P, Carrozzo R, CASARI , GIORGIO NEVIO, Guerrini, R, Parmeggiani, L, Bonanni, P, Carrozzo, R, and Casari, GIORGIO NEVIO
- Published
- 2000
7. Genetic analysis of photoparoxysmal response
- Author
-
Pinto, D, DE HAAN GJ, KASTELEIJN NOLST TRENITE, D, Rudolf, G, Parain, D, DA SILVA AM, Neubauer, B, Pedersen, B, PLOOS VAN AMSTEL JK, Stroink, H, Parmeggiani, L, Picciolo, M, Brinciotti, Mario, Friis, Ml, Bonanni, P, Covanis, T, Lindhout, D, and Koeleman, B.
- Subjects
epilepsy ,genetics ,photoparoxysmal response - Published
- 2002
8. Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy
- Author
-
Marini, C, Darra, F, Specchio, N, Mei, D, Terracciano, A, Parmeggiani, L, Ferrari, A, Sicca, F, Mastrangelo, M, Spaccini, L, Canopoli, Ml, Cesaroni, E, Zamponi, N, Caffi, L, Ricciardelli, P, Grosso, S, Pisano, T, Canevini, Mp, Granata, T, Accorsi, P, Battaglia, Domenica Immacolata, Cusmai, R, Vigevano, F, Dalla Bernardina, B, Guerrini, R., Battaglia, Domenica Immacolata (ORCID:0000-0003-0491-4021), Marini, C, Darra, F, Specchio, N, Mei, D, Terracciano, A, Parmeggiani, L, Ferrari, A, Sicca, F, Mastrangelo, M, Spaccini, L, Canopoli, Ml, Cesaroni, E, Zamponi, N, Caffi, L, Ricciardelli, P, Grosso, S, Pisano, T, Canevini, Mp, Granata, T, Accorsi, P, Battaglia, Domenica Immacolata, Cusmai, R, Vigevano, F, Dalla Bernardina, B, Guerrini, R., and Battaglia, Domenica Immacolata (ORCID:0000-0003-0491-4021)
- Abstract
Mutations of the protocadherin19 gene (PCDH19) cause a female-related epilepsy of variable severity, with or without mental retardation and autistic features. Despite the increasing number of patients and mutations reported, the epilepsy phenotype associated with PCDH19 mutations is still unclear. We analyzed seizure semiology through ictal video-electroencephalography (EEG) recordings in a large series of patients.
- Published
- 2012
9. Protocadherin 19 mutations in girls with infantile-onset epilepsy
- Author
-
Marini, C, Mei, Daniele, Parmeggiani, L, Norci, V, Calado, E, Ferrari, A, Moreira, A, Pisano, T, Specchio, N, Vigevano, F, Battaglia, Domenica Immacolata, Guerrini, R., Battaglia, Domenica Immacolata (ORCID:0000-0003-0491-4021), Marini, C, Mei, Daniele, Parmeggiani, L, Norci, V, Calado, E, Ferrari, A, Moreira, A, Pisano, T, Specchio, N, Vigevano, F, Battaglia, Domenica Immacolata, Guerrini, R., and Battaglia, Domenica Immacolata (ORCID:0000-0003-0491-4021)
- Abstract
To explore the causative role of PCDH19 gene (Xq22) in female patients with epilepsy.
- Published
- 2010
10. Adenosine A1 receptor expression during the transition from compensated pressure overload hypertrophy to heart failure
- Author
-
Perlini, S, Arosio, B, Parmeggiani, L, Santambrogio, D, Palladini, G, Tozzi, R, Gatti, C, Annoni, G, Meyer, T, Ferrari, A, Meyer, TE, Ferrari, AU, ANNONI, GIORGIO, Perlini, S, Arosio, B, Parmeggiani, L, Santambrogio, D, Palladini, G, Tozzi, R, Gatti, C, Annoni, G, Meyer, T, Ferrari, A, Meyer, TE, Ferrari, AU, and ANNONI, GIORGIO
- Abstract
Objectives Myocardial adenosine is increased in pressureoverload hypertrophy (POH) and exerts important cardioprotective effects that delay transition to left ventricular failure. Adenosine-mediated signaling is attenuated in POH, but whether this depends on receptor or postreceptor defects is unknown. We therefore examined left ventricular adenosine A(1)-receptor gene and protein expression in experimental POH. Methods Six week-old Sprague-Dawley rats were subjected to abdominal aortic banding (group B) or sham operation (group S). Echocardiography and left ventricular catheterization were performed 10 weeks later under ketamine anesthesia. Left ventricular and lung weight indices were obtained postmortem. A(1)-Receptor mRNA and protein expression were measured in samples from left ventricular, right ventricular and aortic arch tissue. Group B rats were subgrouped as having compensated or decompensated hypertrophy according to the absence or presence of lung congestion (lung weight index below or above mean +/- 2SD compared with group S rats). Results Both mRNA and protein A-I-receptor expression were significantly increased in compensated group B versus group S rats (by, respectively, 37 and 77%; both P < 0.01). This was not observed in decompensated group B rats. No consistent gene or receptor expression changes were observed in right ventricular or aortic tissues. Conclusions In compensated POH, increased interstitial adenosine concentrations are accompanied by increased expression of the specific receptor mediating the major cardioprotective effects of this autacoid. Such overexpression is no longer detectable once the transition from POH to left ventricular failure has occurred. These observations may have pathophysiological and, in perspective, therapeutic relevance to the course of hypertensive heart disease. J Hypertens 25:449-454 (c) 2007 Lippincott Williams & Wilkins.
- Published
- 2007
11. Clinical and Neurophysiological features of different forms of epileptic falls
- Author
-
Rubboli, G., Michelucci, R., Valzania, F., Parmeggiani, L., Meletti, Stefano, Gardella, E., Rizzi, R., Zaniboni, A., and Tassinari, C. A.
- Subjects
epilepsy ,falling seizures ,focal - Published
- 1997
12. Dipole source estimation suggests similar generators for spontaneous spikes, tapping evoked spikes and N60 SEP component in benign rolandic epilepsy | [Il calcolo delle sorgenti suggerisce generatori simili per le punte spontanee, le punte evocate da tapping e la componente N60 dei PES nell'epilessia benigna a punte rolandiche]
- Author
-
Rubboli, G., Plasmati, R., Parmeggiani, L., Meletti, Stefano, Gardella, E., Pastorelli, F., D'Orsi, G., and Tassinari, C. A.
- Subjects
Benign rolandic epilepsy ,Dipoles ,Tapping evoked spikes ,Benign rolandic epilepsy, Dipoles, Tapping evoked spikes - Published
- 1997
13. Neurophysiological study of paroxysmal EEG activity during 'electrical status epilepticus during sleep' in a patient with Landau-Kleffner syndrome | [Studio neurofisiologico delle attivita parossistiche durante 'stato di male elettrico durante il sonno' in un paziente con sindrome di Landau- Kleffner]
- Author
-
Rubboli, G., Volpi, L., Parmeggiani, L., Meletti, Stefano, Gardella, E., Zamagni, M., Pastoralli, F., Bisulli, F., Zaniboni, A., Riguzzi, P., Rizzi, R., and Tassinari, C. A.
- Subjects
Computerized EEG ,Computerized EEG, ESES, Landau-Kleffner syndrome ,ESES ,Landau-Kleffner syndrome - Published
- 1996
14. Epileptic negative myoclonus
- Author
-
Tassinari, C. A., Rubboli, G., Parmeggiani, L., Valzani, A. F., Plasmati, R., Riguzzi, P., Michelucci, R., Volpi, L., Passarelli, D., Fontana, E., and DALLA BERNARDINA, Bernardo
- Published
- 1995
15. Aloe-emodin quinone pretreatment reduces acute liver injury induced by carbon tetrachloride
- Author
-
Arosio, B, Gagliano, N, Fusaro, L, Parmeggiani, L, Tagliabue, J, Galetti, P, De Castri, D, Mocheni, C, Annoni, G, Fusaro, LMP, ANNONI, GIORGIO, Arosio, B, Gagliano, N, Fusaro, L, Parmeggiani, L, Tagliabue, J, Galetti, P, De Castri, D, Mocheni, C, Annoni, G, Fusaro, LMP, and ANNONI, GIORGIO
- Abstract
Aloe contains several active compounds including aloin, a C-glycoside that can be hydrolyzed in the gut to form aloe-emodin anthrone which, in turn, is auto-oxidized to the quinone aloe-emodin. On the basis of the claimed hepatoprotective activity of some antraquinones, we studied aloe-emodin in a rat model of carbon tetrachloride (CCl4) intoxication, since this xenobiotic induces acute liver damage by lipid peroxidation subsequent to free radical production. Twelve rats were treated with CCl4 (3 mg/kg) intraperitoneally and six were protected with two intraperitoneally injections of aloe-emodin (50 mg/kg; CCl4+aloe-emodin); six other rats were only aloe-emodin injected (aloe-emodin) and six were untreated (control). Histological examination of the livers showed less marked lesions in the CCl4+aloe-emodin rats than in tho se treated wi th CCl4 alone, and this was confirmed by the serum levels of L-aspartate-2- oxoglutate-aminotransferase (394+/-38.6 UI/l in CCl4, 280+/-24.47 UI/l in CCl4+aloe-emodin rats; P<0.05). We also quantified changes in hepatic albumin and tumour necrosis factor-
mRNAs. Albumin mRNA expression was significantly lower only in the liver of CCl4 rats (P<0.05 versus control) and was only slightly reduced in the CCl4+aloe-emodin rats. In contrast tumour necrosis factor- mRNA was significantly higher (P<0.05) in the CCl4, than the control rats and almost equal in the CCl4+aloe-emodin, aloe-emodin and control groups. In conclusion, aloe-emodin appears to have some protective effect not only against hepatocyte death but also on the inflammatory response subsequent to lipid peroxidation. - Published
- 2000
16. Electroclinical features of idiopathic generalised epilepsy with persisting absences in adult life.
- Author
-
Michelucci, R, primary, Rubboli, G, additional, Passarelli, D, additional, Riguzzi, P, additional, Volpi, L, additional, Parmeggiani, L, additional, Rizzi, R, additional, Gardella, E, additional, and Tassinari, C A, additional
- Published
- 1996
- Full Text
- View/download PDF
17. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2.
- Author
-
Guerrini, R, Bonanni, P, Patrignani, A, Brown, P, Parmeggiani, L, Grosse, P, Brovedani, P, Moro, F, Aridon, P, Carrozzo, R, and Casari, G
- Published
- 2001
- Full Text
- View/download PDF
18. Les orientations prédominantes en Italie, en matière de concentrations maximales tolérables pour les toxiques industrielles
- Author
-
Parmeggiani, L.
- Published
- 1961
- Full Text
- View/download PDF
19. Alpha interferon in the treatment of symptomatic myelofibrosis with myeloid metaplasia.
- Author
-
UCL - MD/MINT - Département de médecine interne, Parmeggiani, L, Ferrant, Augustin, Rodhain, J., Michaux, Jean-Louis, Sokal, G., UCL - MD/MINT - Département de médecine interne, Parmeggiani, L, Ferrant, Augustin, Rodhain, J., Michaux, Jean-Louis, and Sokal, G.
- Abstract
2 patients with myelofibrosis and myeloid metaplasia had symptomatic splenomegaly and were treated with interferon alpha-2c (IFN alpha-2c). The splenic pain and pressure symptoms disappeared, accompanied by a decrease in the size of the spleen. However, the peripheral blood count worsened and no improvement in the bone marrow fibrosis could be observed.
- Published
- 1987
20. Epileptic negative myoclonus
- Author
-
Carlo Alberto Tassinari, Rubboli, G., Parmeggiani, L., Valzania, F., Plasmati, R., Riguzzi, P., Michelucci, R., Volpi, L., Passarelli, D., and Meletti, S.
- Subjects
epilepsy ,negative myoclonus ,back-averaging ,Brain Mapping ,Seizures ,Humans ,Neurophysiology ,Electroencephalography ,Epilepsies, Myoclonic - Abstract
ENM is an etiologically heterogeneous disorder clinically evident as brief (less than 500 msec) lapses of tonic muscular contraction which seems to be related to lesions or dysfunction of different anatomofunctional levels of the CNS (Fig. 13). ENM can occur in heterogeneous epileptic disorders, ranging from benign syndromic conditions (such as BECTS) to focal static lesional epilepsy, as in neuronal migration disorders, and even to severe static or progressive myoclonic encephalopathies (PMEs). Neurophysiological studies in patients with ENM lead to the following conclusions: 1. A cortical origin of ENM is supported by EEG mapping and dipole analysis of spikes related to the ENM. In particular, our data suggest that the focal spike is a paroxysmal event involving, primarily or secondarily, the centroparietal and frontal "supplementary" motor areas. 2. A cortical inhibitory active mechanism for the genesis of ENM is supported by the occurrence of a decreased motor response to TMS, with preserved spinal excitability as demonstrated by the persistence of F waves. A "cortical motor outflow inhibition" related to spike-and-wave discharges was suggested by Gloor in his Lennox lecture (34). The cortical reflex negative myoclonus, described by Shibasaki et al. (16) in PME, is also consistent with a cortical active inhibitory mechanism. The spike associated with ENM raises new issues about the definition of "interictal" versus "ictal" EEG paroxysmal activity. A single spike on the EEG can be clinically silent (therefore, "interictal") or clinically evident as ENM (then viewed as "ictal"), depending on whether a given group of muscles is at rest or is showing tonic activity (see Fig. 4). These data, from a more general perspective, imply that the motor manifestation related to EEG paroxysmal events can depend not only on amplitude, topography, or intracortical distribution of seizure activity (35), but also on plasticity (36) and on the functional condition of the motor system (37). The variability of latency between the spike and the onset of the muscular inhibition (ranging from 15 to 50 msec, for the upper limbs), and the variability of duration of the ENM itself (from 50 to 400, or more, msec) indicate that ENM could be the result of inhibitory phenomena arising not only from a single cortical "inhibitory" area, but also from subcortical and pontine structures, as discussed by Mori et al. (this volume). The neurophysiological distinction between ENM and postmyoclonic periods of muscular suppression, mainly related to an EGG slow wave, as described by Lance and Adams (2) in the postanoxic action myoclonus is still a matter of discussion (38, 39). This is also the case for other movement disorders combining action myoclonus and epilepsy-as described in Ramsay Hunt syndrome (30), now better referred to as Unverricht-Lundborg syndrome (40) (Fig. 14). In these conditions, myoclonia and muscular silent periods are inconstantly associated with paroxysmal EEG discharges, suggesting a possible thalamocortical mechanism rather than a purely cortical one. In the most prolonged muscular inhibitions, both cortical and thalamocortical mechanisms might be implicated. Clearly, our knowledge of ENM is still very limited and gaining further insights into this complex phenomenon is a challenging problem.
21. Encyclopaedia of occupational health and safety.
- Author
-
Parmeggiani, L. and Engel, H. O.
- Subjects
LETTERS to the editor ,ENCYCLOPEDIAS & dictionaries - Abstract
A letter to the editor is presented in response to an article about the review of the "Encyclopaedia of Occupational Health and Safety," in the June 1984 issue.
- Published
- 1984
22. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants
- Author
-
Renzo Guerrini, Francesco Miceli, Elena Cellini, Mario Nappi, Maurizio Taglialatela, Lucio Parmeggiani, Christina A. Gurnett, Maria Virginia Soldovieri, Davide Mei, Miceli, F., Guerrini, R., Nappi, M., Soldovieri, M. V., Cellini, E., Gurnett, C. A., Parmeggiani, L., Mei, D., and Taglialatela, M.
- Subjects
Mutant ,Biology ,loss-of-function variants ,developmental encephalopathie ,gain-of-function variant ,03 medical and health sciences ,Epilepsy ,0302 clinical medicine ,medicine ,Humans ,gain-of-function variants ,Loss function ,030304 developmental biology ,Genetics ,loss-of-function variant ,0303 health sciences ,Sodium channel ,developmental encephalopathies ,epilepsy ,KCNA1 ,potassium channels ,medicine.disease ,Phenotype ,In vitro ,Potassium channel ,Electrophysiology ,Carbamazepine ,Neurology ,Mutation ,Neurology (clinical) ,Kv1.1 Potassium Channel ,030217 neurology & neurosurgery - Abstract
A wide phenotypic spectrum of neurological diseases is associated with KCNA1 (Kv1.1) variants. To investigate the molecular basis of such a heterogeneous clinical presentation and identify the possible correlation with in vitro phenotypes, we compared the functional consequences of three heterozygous de novo variants (p.P403S, p.P405L, and p.P405S) in Kv1.1 pore region found in four patients with severe developmental and epileptic encephalopathy (DEE), with those of a de novo variant in the voltage sensor (p.A261T) identified in two patients with mild, carbamazepine-responsive, focal epilepsy. Patch-clamp electrophysiology was used to investigate the functional properties of mutant Kv1.1 subunits, both expressed as homomers and heteromers with wild-type Kv1.1 subunits. KCNA1 pore mutations markedly decreased (p. P405S) or fully suppressed (p. P403S, p. P405L) Kv1.1-mediated currents, exerting loss-of-function (LoF) effects. By contrast, channels carrying the p.A261T variant exhibited a hyperpolarizing shift of the activation process, consistent with a gain-of-function (GoF) effect. The present results unveil a novel correlation between in vitro phenotype (GoF vs LoF) and clinical course (mild vs severe) in KCNA1-related phenotypes. The excellent clinical response to carbamazepine observed in the patients carrying the A261T variant suggests an exquisite sensitivity of KCNA1 GoF to sodium channel inhibition that should be further explored.
- Published
- 2021
23. Autosomal recessive rolandic epilepsy with paroxysmal exercise-induced dystonia and writer's cramp: delineation of the syndrome and gene mapping to chromosome 16p12-11.2
- Author
-
Renzo Guerrini, Paolo Aridon, Andrea Ballabio, Massimo Piccirilli, Lucio Parmeggiani, Giorgio Casari, Nardo Nardocci, Maurizio De Fusco, Romeo Carrozzo, Paolo Bonanni, Guerrini, R, Bonanni, P, Nardocci, N, Parmeggiani, L, Piccirilli, M, DE FUSCO, M, Aridon, P, Ballabio, Andrea, Carrozzo, R, Casari, G., De Fusco, M, Ballabio, A, and Casari, GIORGIO NEVIO
- Subjects
Adult ,Male ,Handwriting ,Paroxysmal nonkinesigenic dyskinesia ,Genetic Linkage ,Paroxysmal exercise-induced dystonia ,Neuropsychological Tests ,Epilepsy ,Autosomal recessive trait ,Evoked Potentials, Somatosensory ,medicine ,Humans ,Child ,Muscle Cramp ,Dystonia ,Genetics ,Blinking ,Electromyography ,Writer's cramp ,Chromosome Mapping ,Electroencephalography ,Syndrome ,medicine.disease ,Epilepsy, Rolandic ,Pedigree ,Rolandic epilepsy ,Neurology ,Paroxysmal dystonia ,Anticonvulsants ,Female ,Neurology (clinical) ,Psychology ,Neuroscience ,Chromosomes, Human, Pair 16 - Abstract
We describe a pedigree in which 3 members in the same generation are affected by Rolandic epilepsy (RE), paroxysmal exercise-induced dystonia (PED), and writer's cramp (WC), Both the seizures and paroxysmal dystonia had a strong age-related expression that peaked during childhood, whereas the WC, also appearing in childhood has been stable since diagnosis. Genome-wide linkage analysis performed under the assumption of recessive inheritance identified a common homozygous haplotype in a critical region spanning 6 cM between markers D16S3133 and D16S3131 on chromosome 1.6,. cosegregating with the affected phenotype and producing a multipoint LOD score value of 3.68. Although its features are unique, this syndrome presents striking analogies with the autosomal dominant infantile convulsions and paroxysmal coreoathetosis (ICCA) syndrome, linked to a 10 cM region between D16S401 and D16S517, which entirely includes the 6 cM of the RE-PED-WC critical region. The same gene map be responsible for both RE-PED-WC and ICCA, with specific mutations explaining each of these Mendelian disorders. This report shows that idiopathic focal disorders such as epilepsy and dystonia, can. be caused by: the same genetic abnormality, may have a transient expression, and may be inherited as an autosomal recessive trait.
- Published
- 1999
24. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2
- Author
-
Pascal Grosse, Giorgio Casari, Paola Brovedani, Paolo Bonanni, Peter Brown, Romeo Carrozzo, Andrea Patrignani, Francesca Moro, Paolo Aridon, Lucio Parmeggiani, Renzo Guerrini, Guerrini, R, Bonanni, P, Patrignani, A, Brown, P, Parmeggiani, L, Grosse, P, Brovedani, P, Moro, F, Aridon, P, Carrozzo, R, and Casari, GIORGIO NEVIO
- Subjects
Adult ,Male ,Benign adult familial myoclonic epilepsy ,Genetic Linkage ,Epilepsies, Myoclonic ,Neurological disorder ,Neuropsychological Tests ,Electroencephalography ,Magnetics ,Epilepsy ,Epilepsy, Complex Partial ,Evoked Potentials, Somatosensory ,Reflex ,medicine ,Humans ,Evoked potential ,Aged ,Genes, Dominant ,Aged, 80 and over ,Family Health ,medicine.diagnostic_test ,Middle Aged ,medicine.disease ,Electric Stimulation ,Pedigree ,Chromosomes, Human, Pair 2 ,Epilepsy syndromes ,Evoked Potentials, Visual ,Myoclonic epilepsy ,Female ,Epilepsy, Tonic-Clonic ,Neurology (clinical) ,medicine.symptom ,Psychology ,Neuroscience ,Myoclonus - Abstract
We describe a pedigree in which eight individuals presented with a non-progressive disorder with onset between the ages of 12 and 50 years. It was characterized by predominantly distal, semi-continuous rhythmic myoclonus (all patients), generalized tonic-clonic seizures (all patients) and complex partial seizures (three patients). Most individuals had rarely suffered seizures and had a normal cognitive level, but three individuals with intractable seizures had mild mental retardation. The pattern of inheritance was autosomal dominant with high penetrance. We defined this disorder as autosomal dominant cortical myoclonus and epilepsy (ADCME). All patients had frontotemporal as well as generalized interictal EEG abnormalities. A neurophysiological study of the myoclonus suggested a cortical origin. Back-averaging of the data generated a series of waves with a frequency that mirrored the frequency of EMG bursts. Frequency analysis identified significant peaks with coherence between EMG and EEG, which were recorded over the contralateral rolandic area in five patients. The frequency of coherence was 8-25 Hz and phase spectra confirmed that EEG activity preceded EMG activity by 8-15 ms. In two individuals there was also significant coherence between the ipsilateral EEG and EMG, consistent with the transcallosal spread of myoclonic activity. The C-reflex at rest was enhanced and somatosensory and visual evoked potentials were of high amplitude. The resting motor threshold intensity to transcranial magnetic stimulation was significantly reduced (38%; SD +/- 7; P = 0.01) and the post-motor evoked potential silent period (101 ms; SEM +/- 10) was significantly shortened compared with the controls (137 ms; SEM +/- 18). These clinical and neuro- physiological characteristics suggest diffuse cortical hyperexcitability and high propensity for intra-hemispheric and inter-hemispheric cortical spread, as well as rhythmic myoclonic activity. Genome-wide linkage analysis identified a critical region spanning 12.4 cM between markers D2S2161 and D2S1897 in 2p11.1-q12.2, with a maximum two-point LOD score of 3.46 at Theta 0.0 for marker D2S2175. Multipoint LOD score values, reaching 3.74 around D2S2175, localize the ADCME gene to the centromeric region of chromosome 2. The exclusion of the locus for familial adult myoclonic epilepsy on chromosome 8q23.3-q24 from linkage to our family and the new localization of the responsible gene to chromosome 2cen, together with the different phenotype, define a new epilepsy syndrome. We hypothesize that the responsible gene causes cortical hyperexcitability that is widespread but particularly involves the frontotemporal circuits.
25. Bilateral temporal lobe dysplasia and seizure onset associated with biallelic CNTNAP2 variants.
- Author
-
Panza N, Bianchini C, Cetica V, Balestrini S, Barba C, Ferrari AR, Mei D, Parmeggiani L, Parrini E, and Guerrini R
- Subjects
- Child, Humans, Electroencephalography, Temporal Lobe diagnostic imaging, Temporal Lobe surgery, Seizures genetics, Membrane Proteins genetics, Nerve Tissue Proteins genetics, Epilepsy, Temporal Lobe genetics, Epilepsy, Temporal Lobe surgery, Epilepsy complications
- Abstract
Biallelic CNTNAP2 variants have been associated with Pitt-Hopkins-like syndrome. We describe six novel and one previously reported patients from six independent families and review the literature including 64 patients carrying biallelic CNTNAP2 variants. Initial reports highlighted intractable focal seizures and the failure of epilepsy surgery in children, but subsequent reports did not expand on this aspect. In all our patients (n = 7), brain MRI showed bilateral temporal gray/white matter blurring with white matter high signal intensity, more obvious on the T2-FLAIR sequences, consistent with bilateral temporal lobe dysplasia. All patients had focal seizures with temporal lobe onset and semiology, which were recorded on EEG in five, showing bilateral independent temporal onset in four. Epilepsy was responsive to anti-seizure medications in two patients (2/7, 28.5%), and pharmaco-resistant in five (5/7, 71.5%). Splice-site variants identified in five patients (5/7, 71.5%) were the most common mutational finding. Our observation expands the phenotypic and genetic spectrum of biallelic CNTNAP2 alterations focusing on the neuroimaging features and provides evidence for an elective bilateral anatomoelectroclinical involvement of the temporal lobes in the associated epilepsy, with relevant implications on clinical management., (© 2023 The Authors. Epilepsia Open published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.)
- Published
- 2024
- Full Text
- View/download PDF
26. Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants.
- Author
-
Miceli F, Guerrini R, Nappi M, Soldovieri MV, Cellini E, Gurnett CA, Parmeggiani L, Mei D, and Taglialatela M
- Subjects
- Carbamazepine therapeutic use, Humans, Kv1.1 Potassium Channel genetics, Mutation genetics, Phenotype, Epilepsy drug therapy, Epilepsy genetics
- Abstract
A wide phenotypic spectrum of neurological diseases is associated with KCNA1 (Kv1.1) variants. To investigate the molecular basis of such a heterogeneous clinical presentation and identify the possible correlation with in vitro phenotypes, we compared the functional consequences of three heterozygous de novo variants (p.P403S, p.P405L, and p.P405S) in Kv1.1 pore region found in four patients with severe developmental and epileptic encephalopathy (DEE), with those of a de novo variant in the voltage sensor (p.A261T) identified in two patients with mild, carbamazepine-responsive, focal epilepsy. Patch-clamp electrophysiology was used to investigate the functional properties of mutant Kv1.1 subunits, both expressed as homomers and heteromers with wild-type Kv1.1 subunits. KCNA1 pore mutations markedly decreased (p. P405S) or fully suppressed (p. P403S, p. P405L) Kv1.1-mediated currents, exerting loss-of-function (LoF) effects. By contrast, channels carrying the p.A261T variant exhibited a hyperpolarizing shift of the activation process, consistent with a gain-of-function (GoF) effect. The present results unveil a novel correlation between in vitro phenotype (GoF vs LoF) and clinical course (mild vs severe) in KCNA1-related phenotypes. The excellent clinical response to carbamazepine observed in the patients carrying the A261T variant suggests an exquisite sensitivity of KCNA1 GoF to sodium channel inhibition that should be further explored., (© 2021 The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.)
- Published
- 2022
- Full Text
- View/download PDF
27. Spinal cord involvement and paroxysmal events in "Infantile Onset Transient Hypomyelination" due to TMEM63A mutation.
- Author
-
Tonduti D, Mura E, Masnada S, Bertini E, Aiello C, Zini D, Parmeggiani L, Cantalupo G, Talenti G, Veggiotti P, Spaccini L, Iascone M, and Parazzini C
- Subjects
- Female, Humans, Infant, Magnetic Resonance Imaging, Mutation genetics, Pelizaeus-Merzbacher Disease diagnostic imaging, Pelizaeus-Merzbacher Disease metabolism, Pelizaeus-Merzbacher Disease pathology, Spinal Cord metabolism, Spinal Cord pathology, Genetic Predisposition to Disease, Membrane Proteins genetics, Myelin Proteolipid Protein genetics, Pelizaeus-Merzbacher Disease genetics, Spinal Cord diagnostic imaging
- Abstract
Monoallelic mutations on TMEM63A have been recently reported as cause of a previously unrecognized disorder named "infantile-onset transient hypomyelination". Clinical and neuroradiological presentation is described as highly similar to Pelizaeus-Merzbacher Disease but evolution over time was surprisingly benign with a progressive spontaneous improving course. We report on a new TMEM63A-mutated girl. The clinical picture was similar to the one already described except for the presence of recurrent episodes of unilateral eyelid twitching, and for the evidence of spinal cord involvement on MRI. These are interesting findings helping in distinguishing this condition from classic PMD since early disease stages. However, additional observations are needed to confirm if these are common features of this condition., (© 2021. The Author(s), under exclusive licence to The Japan Society of Human Genetics.)
- Published
- 2021
- Full Text
- View/download PDF
28. Lamina cribrosa perforation during nasotracheal intubation in neonates: case series and review of the literature.
- Author
-
Lupi F, Staffler A, Parmeggiani L, Klemme M, Dalla Pozza R, Stuefer J, Thorsteinsdottir J, Peraud A, and Flemmer AW
- Abstract
Intracranial penetration during attempted nasotracheal intubation is a potentially devastating complication, which should be carefully evaluated and the risk should be addressed in neonatal resuscitation trainings., Competing Interests: The authors declare that they have no competing interests., (© 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.)
- Published
- 2021
- Full Text
- View/download PDF
29. Unmet needs in the management of functional impairment in patients with chronic pain: a multinational survey.
- Author
-
Karra R, Holten-Rossing S, Mohammed D, Parmeggiani L, Heine M, and Namnún OC
- Subjects
- Humans, Surveys and Questionnaires, Chronic Pain therapy
- Abstract
Background: A survey of European Pain Federation 2019 attendees was conducted to identify unmet needs in chronic pain patients. Materials & methods: Four questions were asked focusing on functional impairment in chronic pain, including who are at increased risk and ways to better identify and manage these patients. Results: In total 143 respondents indicated that key issues were lack of knowledge, lack of resources/time to assess and manage chronic pain and lack of sufficient tools to identify patients at risk for functional impairment. Education and training of primary care physicians, simplified guidelines and practical tools for assessment and use of multidisciplinary teams to treat chronic pain were recommended. Conclusion: There are many unmet needs in the management of functional impairment in chronic pain patients.
- Published
- 2021
- Full Text
- View/download PDF
30. Compound heterozygous SZT2 mutations in two siblings with early-onset epilepsy, intellectual disability and macrocephaly.
- Author
-
Domingues FS, König E, Schwienbacher C, Volpato CB, Picard A, Cantaloni C, Mascalzoni D, Lackner P, Heimbach A, Hoffmann P, Stanzial F, Hicks AA, Parmeggiani L, Benedicenti F, Pellegrin S, Casara G, and Pramstaller PP
- Subjects
- Adult, DNA Mutational Analysis, Epilepsy complications, Epilepsy diagnostic imaging, Humans, Intellectual Disability complications, Intellectual Disability diagnostic imaging, Longitudinal Studies, Magnetic Resonance Imaging, Male, Megalencephaly complications, Megalencephaly diagnostic imaging, Exome Sequencing, Young Adult, Epilepsy genetics, Family Health, Intellectual Disability genetics, Megalencephaly genetics, Mutation genetics, Nerve Tissue Proteins genetics
- Abstract
Purpose: Mutations in SZT2 have been previously reported in several cases of early onset epilepsy and intellectual disability. In this study we investigate potential causal mutations in two male siblings affected by early onset epilepsy, intellectual disability and macrocephaly., Methods: We use family-based whole-exome sequencing to identify candidate variants., Results: We report the identification of two potential causal SZT2 mutations in compound heterozygous state. We observe considerable differences in the clinical phenotype severity of the two affected individuals. The cerebral MRI revealed no abnormalities in the older affected brother, while in the youngest one it revealed a right frontal polymicrogiria. Moreover, while good seizure control was achieved in the older affected individual the younger brother is affected by pharmacoresistant epilepsy, progressive spastic paraplegia, cortical myoclonus and a more severe intellectual disability. We also analyzed the relative location of the reported pathogenic mutations in the SZT2 protein., Conclusion: Variable phenotypic expressivity is observed for this condition, while the location and type of mutations in SZT2 also has a potential impact on epilepsy severity. These findings extend our knowledge of epileptogenic conditions related to SZT2 and mTOR signaling., (Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
31. Defining the electroclinical phenotype and outcome of PCDH19-related epilepsy: A multicenter study.
- Author
-
Trivisano M, Pietrafusa N, Terracciano A, Marini C, Mei D, Darra F, Accorsi P, Battaglia D, Caffi L, Canevini MP, Cappelletti S, Cesaroni E, de Palma L, Costa P, Cusmai R, Giordano L, Ferrari A, Freri E, Fusco L, Granata T, Martino T, Mastrangelo M, Bova SM, Parmeggiani L, Ragona F, Sicca F, Striano P, Specchio LM, Tondo I, Zambrelli E, Zamponi N, Zanus C, Boniver C, Vecchi M, Avolio C, Dalla Bernardina B, Bertini E, Guerrini R, Vigevano F, and Specchio N
- Subjects
- Adolescent, Adult, Age of Onset, Autistic Disorder complications, Autistic Disorder psychology, Child, Child, Preschool, Cohort Studies, Electroencephalography, Female, Humans, Infant, Intellectual Disability complications, Intellectual Disability psychology, Male, Phenotype, Protocadherins, Retrospective Studies, Seizures, Treatment Outcome, Young Adult, Cadherins genetics, Epileptic Syndromes genetics, Epileptic Syndromes therapy
- Abstract
Objective: PCDH19-related epilepsy is an epileptic syndrome with infantile onset, characterized by clustered and fever-induced seizures, often associated with intellectual disability (ID) and autistic features. The aim of this study was to analyze a large cohort of patients with PCDH19-related epilepsy and better define the epileptic phenotype, genotype-phenotype correlations, and related outcome-predicting factors., Methods: We retrospectively collected genetic, clinical, and electroencephalogram (EEG) data of 61 patients with PCDH19-related epilepsy followed at 15 epilepsy centers. All consecutively performed EEGs were analyzed, totaling 551. We considered as outcome measures the development of ID, autistic spectrum disorder (ASD), and seizure persistence. The analyzed variables were the following: gender, age at onset, age at study, genetic variant, fever sensitivity, seizure type, cluster occurrence, status epilepticus, EEG abnormalities, and cognitive and behavioral disorders. Receiver operating characteristic curve analysis was performed to evaluate the age at which seizures might decrease in frequency., Results: At last follow-up (median = 12 years, range = 1.9-42.1 years), 48 patients (78.7%) had annual seizures/clusters, 13 patients (21.3%) had monthly to weekly seizures, and 12 patients (19.7%) were seizure-free for ≥2 years. Receiver operating characteristic analysis showed a significant decrease of seizure frequency after the age of 10.5 years (sensitivity = 81.0%, specificity = 70.0%). Thirty-six patients (59.0%) had ID and behavioral disturbances. ASD was present in 31 patients. An earlier age at epilepsy onset emerged as the only predictive factor for ID (P = 0.047) and ASD (P = 0.014). Conversely, age at onset was not a predictive factor for seizure outcome (P = 0.124)., Significance: We found that earlier age at epilepsy onset is related to a significant risk for ID and ASD. Furthermore, long-term follow-up showed that after the age of 10 years, seizures decrease in frequency and cognitive and behavioral disturbances remain the primary clinical problems., (Wiley Periodicals, Inc. © 2018 International League Against Epilepsy.)
- Published
- 2018
- Full Text
- View/download PDF
32. Clinical features and outcome of 6 new patients carrying de novo KCNB1 gene mutations.
- Author
-
Marini C, Romoli M, Parrini E, Costa C, Mei D, Mari F, Parmeggiani L, Procopio E, Metitieri T, Cellini E, Virdò S, De Vita D, Gentile M, Prontera P, Calabresi P, and Guerrini R
- Abstract
Objective: To describe electroclinical features and outcome of 6 patients harboring KCNB1 mutations., Methods: Clinical, EEG, neuropsychological, and brain MRI data analysis. Targeted next-generation sequencing of a 95 epilepsy gene panel., Results: The mean age at seizure onset was 11 months. The mean follow-up of 11.3 years documented that 4 patients following an infantile phase of frequent seizures became seizure free; the mean age at seizure offset was 4.25 years. Epilepsy phenotypes comprised West syndrome in 2 patients, infantile-onset unspecified generalized epilepsy, myoclonic and photosensitive eyelid myoclonia epilepsy resembling Jeavons syndrome, Lennox-Gastaut syndrome, and focal epilepsy with prolonged occipital or clonic seizures in each and every one. Five patients had developmental delay prior to seizure onset evolving into severe intellectual disability with absent speech and autistic traits in one and stereotypic hand movements with impulse control disorder in another. The patient with Jeavons syndrome evolved into moderate intellectual disability. Mutations were de novo, 4 missense and 2 nonsense, 5 were novel, and 1 resulted from somatic mosaicism., Conclusions: KCNB1 -related manifestations include a spectrum of infantile-onset generalized or focal seizures whose combination leads to early infantile epileptic encephalopathy including West, Lennox-Gastaut, and Jeavons syndromes. Long-term follow-up highlights that following a stormy phase, seizures subside or cease and treatment may be eased or withdrawn. Cognitive and motor functions are almost always delayed prior to seizure onset and evolve into severe, persistent impairment. Thus, KCNB1 mutations are associated with diffuse brain dysfunction combining seizures, motor, and cognitive impairment.
- Published
- 2017
- Full Text
- View/download PDF
33. Focal seizures with affective symptoms are a major feature of PCDH19 gene-related epilepsy.
- Author
-
Marini C, Darra F, Specchio N, Mei D, Terracciano A, Parmeggiani L, Ferrari A, Sicca F, Mastrangelo M, Spaccini L, Canopoli ML, Cesaroni E, Zamponi N, Caffi L, Ricciardelli P, Grosso S, Pisano T, Canevini MP, Granata T, Accorsi P, Battaglia D, Cusmai R, Vigevano F, Dalla Bernardina B, and Guerrini R
- Subjects
- Adolescent, Adult, Affective Symptoms complications, Child, Child, Preschool, Cognition Disorders etiology, Cognition Disorders genetics, Computational Biology, DNA Mutational Analysis, Electroencephalography, Female, Follow-Up Studies, Humans, Neuropsychological Tests, Protocadherins, Seizures complications, Video Recording, Young Adult, Affective Symptoms genetics, Cadherins genetics, Genetic Predisposition to Disease genetics, Mutation genetics, Seizures genetics
- Abstract
Purpose: Mutations of the protocadherin19 gene (PCDH19) cause a female-related epilepsy of variable severity, with or without mental retardation and autistic features. Despite the increasing number of patients and mutations reported, the epilepsy phenotype associated with PCDH19 mutations is still unclear. We analyzed seizure semiology through ictal video-electroencephalography (EEG) recordings in a large series of patients., Methods: We studied 35 patients with PCDH19 gene-related epilepsy and analyzed clinical history and ictal video-EEG recordings obtained in 34 of them., Key Findings: Clusters of focal febrile and afebrile seizures had occurred in 34 patients, at a mean age of 10 months. The predominant and more consistent ictal sign was fearful screaming, occurring in 24 patients (70.5%); it was present since epilepsy onset in 12 and appeared later on, during the course in the remaining 12 patients. In infancy, fearful screaming mainly appeared within the context of seizures with prominent hypomotor semiology, whereas during follow-up it was associated with prominent early motor manifestations. In 16 patients, seizures were video-EEG recorded both at onset and during follow-up: in five patients (31%) seizure semiology remained identical, in 7 (44%) semiology varied and in four patients it was unclear whether ictal semiology changed with age. Three patients (9%) had both focal and generalized seizures, the latter consisting of absences and myoclonus. Ictal EEG during focal seizures showed a prominent involvement of the frontotemporal regions (22 patients). About 45% of patients had an alternating EEG pattern, with the ictal discharge migrating from one hemisphere to the contralateral during the same ictal event. Status epilepticus occurred in 30% of patients. Cognitive impairment occurred in 70%, ranging from mild (42%) to moderate (54%) and severe (4%); autistic features occurred in 28.5%. Direct sequencing detected 33 different heterozygous candidate mutations, 8 of which were novel. Mutations were missense substitutions (48.5%), premature termination (10 frameshift, 4 nonsense, and 2 splice-site mutations; 48.5%), and one in-frame deletion. Thirty candidate mutations (91%) were de novo. No specific genotype-phenotype correlation could be established, as missense and truncating mutations were associated with phenotypes of comparable severity., Significance: Most patients with PCDH19 mutations exhibit a distinctive electroclinical pattern of focal seizures with affective symptoms, suggesting an epileptogenic dysfunction involving the frontotemporal limbic system. Awareness of this distinctive phenotype will likely enhance recognition of this disorder., (Wiley Periodicals, Inc. © 2012 International League Against Epilepsy.)
- Published
- 2012
- Full Text
- View/download PDF
34. Early-onset absence epilepsy and paroxysmal dyskinesia.
- Author
-
Guerrini R, Sanchez-Carpintero R, Deonna T, Santucci M, Bhatia KP, Moreno T, Parmeggiani L, and Bernardina BD
- Subjects
- Adolescent, Adult, Age of Onset, Anticonvulsants therapeutic use, Child, Child, Preschool, Chorea drug therapy, Chorea epidemiology, Comorbidity, Electroencephalography statistics & numerical data, Epilepsy, Absence drug therapy, Epilepsy, Absence epidemiology, Ethosuximide therapeutic use, Female, Humans, Male, Syndrome, Treatment Outcome, Videotape Recording, Chorea diagnosis, Epilepsy, Absence diagnosis
- Abstract
Purpose: To report on the association of childhood absence epilepsy and paroxysmal dyskinesia (PD)., Methods: We describe six patients aged 6 to 27 years (mean, 14 years) who were identified in five centers participating in a European study group. Patients had been followed up clinically from the first symptoms and had been studied with video-EEG recordings of absence seizures, videotaping of dyskinetic attacks, and brain magnetic resonance imaging (MRI)., Results: Four patients were sporadic, and two were siblings. Age at onset of absence seizures was unusually early (range, 3 months to 3 years 6 months; mean, 16 months), with four children having their first episodes within the first year of life, and the remaining two by age 3 years 6 months. Resistance to multiple appropriate drugs was seen in five children, in four of whom absences improved remarkably when ethosuximide was added. Absences remitted between age 8 and 13 years in the three patients in whom follow-up was long enough. Different types of PD were seen including paroxysmal kinesigenic dyskinesia (one patient), paroxysmal exercise-induced dystonia (three patients), and paroxysmal tonic upgaze (two siblings). In most patients, PD appeared at a later age than, co-occurred with, and outlasted absence seizures. Only in the two siblings with tonic upgaze, dyskinetic attacks had an earlier onset. PD improved with increasing age and did not usually produce severe disability., Conclusions: There is a widening spectrum of epilepsy and PD syndromes, within which epilepsy has the characteristics of the common idiopathic syndromes, with some atypical features.
- Published
- 2002
- Full Text
- View/download PDF
35. Different neurophysiologic patterns of myoclonus characterize Lennox-Gastaut syndrome and myoclonic astatic epilepsy.
- Author
-
Bonanni P, Parmeggiani L, and Guerrini R
- Subjects
- Adolescent, Child, Child, Preschool, Electroencephalography methods, Electromyography methods, Epilepsies, Myoclonic physiopathology, Epilepsy physiopathology, Female, Frontal Lobe physiopathology, Humans, Male, Muscle, Skeletal physiopathology, Syndrome, Cerebral Cortex physiopathology, Electroencephalography statistics & numerical data, Electromyography statistics & numerical data, Epilepsies, Myoclonic diagnosis, Epilepsy diagnosis
- Abstract
Purpose: To study the neurophysiologic characteristics of epileptic myoclonus in patients with Lennox-Gastaut syndrome (LGS) and myoclonic astatic epilepsy (MAE)., Methods: Three patients with symptomatic LGS (mean age, 15 years +/- 4) and three with cryptogenic MAE (mean age, 9 years +/- 3) were studied. Temporal relationships between electroencephalographic (EEG) and electromyographic activity were studied by analyzing latencies of EEG activity related to the onset of single myoclonic jerks, by using burst-locked EEG averaging where necessary., Results: LGS: neurophysiologic analysis indicated that jerks and the accompanying premyoclonic spikes showed latency differences between sides (mean +/- SD, 18 +/- 5 ms for both) with a constant leading side in each patient. The premyoclonic spike latency was 20 +/- 10 ms (mean +/- SD). Topographic voltage mapping of the premyoclonic spike peak showed a unilateral frontal distribution. MAE: muscles from both sides were activated synchronously, and the EEG correlate was a generalized spike-wave, in which the negative peak of the spike preceded the generalized jerks by 30 +/- 2 ms (mean +/- SD). Topographic voltage mapping of the premyoclonic spike peak showed a diffuse distribution of the electrical field, predominating over the anterior regions, but not lateralized., Conclusions: These neurophysiologic findings indicate that epileptic myoclonus in LGS originates from a stable generator in the frontal cortex, to spread to contralateral and ipsilateral cortical areas, whereas myoclonus in MAE appears to be a primary generalized epileptic phenomenon.
- Published
- 2002
- Full Text
- View/download PDF
36. Autosomal dominant cortical myoclonus and epilepsy (ADCME) with complex partial and generalized seizures: A newly recognized epilepsy syndrome with linkage to chromosome 2p11.1-q12.2.
- Author
-
Guerrini R, Bonanni P, Patrignani A, Brown P, Parmeggiani L, Grosse P, Brovedani P, Moro F, Aridon P, Carrozzo R, and Casari G
- Subjects
- Adult, Aged, Aged, 80 and over, Electric Stimulation, Electroencephalography, Epilepsies, Myoclonic diagnosis, Epilepsy, Complex Partial diagnosis, Epilepsy, Tonic-Clonic diagnosis, Evoked Potentials, Somatosensory, Evoked Potentials, Visual, Family Health, Female, Genes, Dominant, Humans, Magnetics, Male, Middle Aged, Neuropsychological Tests, Pedigree, Reflex, Chromosomes, Human, Pair 2, Epilepsies, Myoclonic genetics, Epilepsy, Complex Partial genetics, Epilepsy, Tonic-Clonic genetics, Genetic Linkage
- Abstract
We describe a pedigree in which eight individuals presented with a non-progressive disorder with onset between the ages of 12 and 50 years. It was characterized by predominantly distal, semi-continuous rhythmic myoclonus (all patients), generalized tonic-clonic seizures (all patients) and complex partial seizures (three patients). Most individuals had rarely suffered seizures and had a normal cognitive level, but three individuals with intractable seizures had mild mental retardation. The pattern of inheritance was autosomal dominant with high penetrance. We defined this disorder as autosomal dominant cortical myoclonus and epilepsy (ADCME). All patients had frontotemporal as well as generalized interictal EEG abnormalities. A neurophysiological study of the myoclonus suggested a cortical origin. Back-averaging of the data generated a series of waves with a frequency that mirrored the frequency of EMG bursts. Frequency analysis identified significant peaks with coherence between EMG and EEG, which were recorded over the contralateral rolandic area in five patients. The frequency of coherence was 8-25 Hz and phase spectra confirmed that EEG activity preceded EMG activity by 8-15 ms. In two individuals there was also significant coherence between the ipsilateral EEG and EMG, consistent with the transcallosal spread of myoclonic activity. The C-reflex at rest was enhanced and somatosensory and visual evoked potentials were of high amplitude. The resting motor threshold intensity to transcranial magnetic stimulation was significantly reduced (38%; SD +/- 7; P = 0.01) and the post-motor evoked potential silent period (101 ms; SEM +/- 10) was significantly shortened compared with the controls (137 ms; SEM +/- 18). These clinical and neuro- physiological characteristics suggest diffuse cortical hyperexcitability and high propensity for intra-hemispheric and inter-hemispheric cortical spread, as well as rhythmic myoclonic activity. Genome-wide linkage analysis identified a critical region spanning 12.4 cM between markers D2S2161 and D2S1897 in 2p11.1-q12.2, with a maximum two-point LOD score of 3.46 at Theta 0.0 for marker D2S2175. Multipoint LOD score values, reaching 3.74 around D2S2175, localize the ADCME gene to the centromeric region of chromosome 2. The exclusion of the locus for familial adult myoclonic epilepsy on chromosome 8q23.3-q24 from linkage to our family and the new localization of the responsible gene to chromosome 2cen, together with the different phenotype, define a new epilepsy syndrome. We hypothesize that the responsible gene causes cortical hyperexcitability that is widespread but particularly involves the frontotemporal circuits.
- Published
- 2001
- Full Text
- View/download PDF
37. Adolescent onset of idiopathic photosensitive occipital epilepsy after remission of benign rolandic epilepsy.
- Author
-
Guerrini R, Bonanni P, Parmeggiani L, and Belmonte A
- Subjects
- Adolescent, Adult, Age of Onset, Anticonvulsants pharmacology, Anticonvulsants therapeutic use, Child, Preschool, Diagnosis, Differential, Epilepsy drug therapy, Epilepsy physiopathology, Epilepsy, Rolandic drug therapy, Epilepsy, Rolandic physiopathology, Evoked Potentials, Somatosensory, Evoked Potentials, Visual, Female, Follow-Up Studies, Humans, Sleep physiology, Somatosensory Cortex physiopathology, Electroencephalography, Epilepsy diagnosis, Epilepsy, Rolandic diagnosis, Occipital Lobe physiopathology, Photic Stimulation
- Abstract
Purpose: We describe 2 girls, aged 19 years, who experienced a rolandic seizure at ages 4 and 5, respectively, together with the interictal EEG features of benign rolandic epilepsy (BRE). In adolescence both patients developed photosensitive occipital seizures accompanied by spontaneous and photic-induced occipital EEG paroxysms., Methods: We have been following 33 patients with a history of BRE, between ages 12 and 28 years (mean 17 years). Twenty-one of these patients had experienced their last rolandic seizure before the age of 10 years and 9 of them had been without treatment since age 11 or earlier. In 2 of these 9 patients, other types of seizures recurred after remission of BRE. Clinical, EEG, and evoked potential findings on these 2 patients are presented., Results: After having experienced BRE, both patients suffered partial seizures from age 12, with elementary visual hallucinations, visual blurring, slow head turning, cephalic pain, epigastric discomfort, unresponsiveness, and vomiting. Seizure onset was related to watching TV or exposure to bright light. EEG showed interictal occipital spikes, and a photoparoxysmal response limited to the occipital lobes. Visual evoked potentials were greatly increased in amplitude. One patient had two visual attacks only and remained seizure free after 4 years of follow-up, while the other had seizures controlled by an association of valproate and carbamazepine., Conclusions: Clinical and neurophysiological characteristics suggest that these two patients may have presented different age-related expressions within the spectrum of a benign seizure susceptibility syndrome rather than sharply distinct epilepsy syndromes.
- Published
- 1997
- Full Text
- View/download PDF
38. Graphite pneumoconiosis.
- Author
-
PARMEGGIANI L
- Subjects
- Humans, Graphite, Pneumoconiosis, Pulmonary Fibrosis
- Published
- 1950
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.